Schonfeld Strategic Advisors’s CryoPort CYRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-57,700
Closed -$1.02M 2234
2024
Q1
$1.02M Buy
+57,700
New +$914K 0.01% 1217
2022
Q4
Sell
-18,500
Closed -$450K 2669
2022
Q3
$450K Buy
+18,500
New +$637K ﹤0.01% 1826
2022
Q2
Sell
-11,100
Closed -$388K 2620
2022
Q1
$388K Buy
11,100
+7,580
+215% +$287K ﹤0.01% 1529
2021
Q4
$208K Buy
+3,520
New +$244K ﹤0.01% 1708
2021
Q3
Sell
-9,154
Closed -$578K 2211
2021
Q2
$578K Buy
+9,154
New +$515K 0.01% 1125
2018
Q4
Sell
-155,062
Closed -$1.99M 1091
2018
Q3
$1.99M Buy
155,062
+55,062
+55% +$786K 0.09% 285
2018
Q2
$1.58M Buy
+100,000
New +$1.06M 0.09% 312

Other funds holding CYRX

Schonfeld Strategic Advisors's CYRX Position: Q2 2024 in Review

Schonfeld Strategic Advisors sold out of CryoPort (CYRX) in Q2 2024, closing a stake of 57,700 shares — an estimated $1.02M sold.

Schonfeld Strategic Advisors first reported a position in CYRX in Q2 2018 and held it in 7 quarters. The position peaked at $1.99M in Q3 2018. 159 funds tracked by Wall St. Rank hold CYRX as of Q2 2024.

  • Schonfeld Strategic Advisors reported no remaining CryoPort position as of Q2 2024 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 57,700 CryoPort shares in Q2 2024, an estimated $1.02M.
  • Schonfeld Strategic Advisors first reported a position in CryoPort in Q2 2018 and held it in 7 quarters.
  • Schonfeld Strategic Advisors's CryoPort position peaked at $1.99M in Q3 2018.
  • 159 funds tracked by Wall St. Rank held CryoPort as of Q2 2024.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.